nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—ALB—acquired immunodeficiency syndrome	0.234	1	CbGaD
Furosemide—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0735	0.145	CbGbCtD
Furosemide—SLC22A11—Zidovudine—acquired immunodeficiency syndrome	0.0722	0.142	CbGbCtD
Furosemide—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0557	0.11	CbGbCtD
Furosemide—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0475	0.0935	CbGbCtD
Furosemide—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.042	0.0827	CbGbCtD
Furosemide—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0417	0.0821	CbGbCtD
Furosemide—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0417	0.0821	CbGbCtD
Furosemide—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0309	0.0609	CbGbCtD
Furosemide—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0293	0.0576	CbGbCtD
Furosemide—ALB—Saquinavir—acquired immunodeficiency syndrome	0.026	0.0511	CbGbCtD
Furosemide—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0249	0.049	CbGbCtD
Furosemide—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0226	0.0445	CbGbCtD
Furosemide—CA6—saliva—acquired immunodeficiency syndrome	0.00648	0.103	CbGeAlD
Furosemide—SLC12A1—blood plasma—acquired immunodeficiency syndrome	0.00218	0.0345	CbGeAlD
Furosemide—CA1—nerve—acquired immunodeficiency syndrome	0.00198	0.0314	CbGeAlD
Furosemide—PGD—blood plasma—acquired immunodeficiency syndrome	0.00179	0.0284	CbGeAlD
Furosemide—CA4—nerve—acquired immunodeficiency syndrome	0.00155	0.0245	CbGeAlD
Furosemide—CA1—blood plasma—acquired immunodeficiency syndrome	0.0015	0.0238	CbGeAlD
Furosemide—CA7—digestive system—acquired immunodeficiency syndrome	0.00112	0.0177	CbGeAlD
Furosemide—CA9—digestive system—acquired immunodeficiency syndrome	0.000983	0.0156	CbGeAlD
Furosemide—PGD—retina—acquired immunodeficiency syndrome	0.00098	0.0155	CbGeAlD
Furosemide—CA2—blood plasma—acquired immunodeficiency syndrome	0.00097	0.0154	CbGeAlD
Furosemide—SLCO2A1—skin of body—acquired immunodeficiency syndrome	0.000965	0.0153	CbGeAlD
Furosemide—SLC22A11—digestive system—acquired immunodeficiency syndrome	0.000861	0.0137	CbGeAlD
Furosemide—PGD—skin of body—acquired immunodeficiency syndrome	0.000861	0.0136	CbGeAlD
Furosemide—CA14—spinal cord—acquired immunodeficiency syndrome	0.000855	0.0136	CbGeAlD
Furosemide—SLC12A1—blood—acquired immunodeficiency syndrome	0.000797	0.0126	CbGeAlD
Furosemide—SLC12A1—spinal cord—acquired immunodeficiency syndrome	0.000768	0.0122	CbGeAlD
Furosemide—CA12—digestive system—acquired immunodeficiency syndrome	0.000727	0.0115	CbGeAlD
Furosemide—PGD—lymphoid tissue—acquired immunodeficiency syndrome	0.000697	0.0111	CbGeAlD
Furosemide—PGD—digestive system—acquired immunodeficiency syndrome	0.000688	0.0109	CbGeAlD
Furosemide—SLCO2A1—vagina—acquired immunodeficiency syndrome	0.000682	0.0108	CbGeAlD
Furosemide—CA7—brain—acquired immunodeficiency syndrome	0.000661	0.0105	CbGeAlD
Furosemide—PGD—blood—acquired immunodeficiency syndrome	0.000656	0.0104	CbGeAlD
Furosemide—SLC12A1—nervous system—acquired immunodeficiency syndrome	0.000647	0.0103	CbGeAlD
Furosemide—SLCO2A1—lung—acquired immunodeficiency syndrome	0.000645	0.0102	CbGeAlD
Furosemide—PGD—bone marrow—acquired immunodeficiency syndrome	0.000634	0.0101	CbGeAlD
Furosemide—PGD—spinal cord—acquired immunodeficiency syndrome	0.000632	0.01	CbGeAlD
Furosemide—SLC12A1—central nervous system—acquired immunodeficiency syndrome	0.000623	0.00988	CbGeAlD
Furosemide—CA5B—blood—acquired immunodeficiency syndrome	0.000621	0.00985	CbGeAlD
Furosemide—PGD—vagina—acquired immunodeficiency syndrome	0.000608	0.00964	CbGeAlD
Furosemide—CA12—lung—acquired immunodeficiency syndrome	0.000607	0.00963	CbGeAlD
Furosemide—SLCO2A1—nervous system—acquired immunodeficiency syndrome	0.000597	0.00947	CbGeAlD
Furosemide—CA1—lymphoid tissue—acquired immunodeficiency syndrome	0.000583	0.00925	CbGeAlD
Furosemide—CA1—digestive system—acquired immunodeficiency syndrome	0.000576	0.00913	CbGeAlD
Furosemide—CA5B—vagina—acquired immunodeficiency syndrome	0.000576	0.00913	CbGeAlD
Furosemide—SLCO2A1—central nervous system—acquired immunodeficiency syndrome	0.000575	0.00912	CbGeAlD
Furosemide—PGD—lung—acquired immunodeficiency syndrome	0.000575	0.00912	CbGeAlD
Furosemide—CA12—nervous system—acquired immunodeficiency syndrome	0.000562	0.00892	CbGeAlD
Furosemide—CA14—brain—acquired immunodeficiency syndrome	0.000551	0.00874	CbGeAlD
Furosemide—CA1—blood—acquired immunodeficiency syndrome	0.000549	0.0087	CbGeAlD
Furosemide—CA5B—lung—acquired immunodeficiency syndrome	0.000545	0.00864	CbGeAlD
Furosemide—CA12—central nervous system—acquired immunodeficiency syndrome	0.000541	0.00858	CbGeAlD
Furosemide—PGD—nervous system—acquired immunodeficiency syndrome	0.000532	0.00844	CbGeAlD
Furosemide—CA2—retina—acquired immunodeficiency syndrome	0.000531	0.00843	CbGeAlD
Furosemide—CA1—bone marrow—acquired immunodeficiency syndrome	0.000531	0.00842	CbGeAlD
Furosemide—CA1—spinal cord—acquired immunodeficiency syndrome	0.000528	0.00838	CbGeAlD
Furosemide—SLC22A5—retina—acquired immunodeficiency syndrome	0.000523	0.00829	CbGeAlD
Furosemide—PGD—central nervous system—acquired immunodeficiency syndrome	0.000513	0.00813	CbGeAlD
Furosemide—CA5B—nervous system—acquired immunodeficiency syndrome	0.000504	0.008	CbGeAlD
Furosemide—SLC12A1—brain—acquired immunodeficiency syndrome	0.000495	0.00785	CbGeAlD
Furosemide—CA5B—central nervous system—acquired immunodeficiency syndrome	0.000485	0.0077	CbGeAlD
Furosemide—CA1—lung—acquired immunodeficiency syndrome	0.000481	0.00763	CbGeAlD
Furosemide—SLC22A6—brain—acquired immunodeficiency syndrome	0.00048	0.00761	CbGeAlD
Furosemide—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000474	0.00752	CbGeAlD
Furosemide—CA2—skin of body—acquired immunodeficiency syndrome	0.000467	0.0074	CbGeAlD
Furosemide—SLC22A8—blood—acquired immunodeficiency syndrome	0.000463	0.00734	CbGeAlD
Furosemide—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.000459	0.00728	CbGeAlD
Furosemide—SLCO2A1—brain—acquired immunodeficiency syndrome	0.000457	0.00724	CbGeAlD
Furosemide—ABCC2—blood—acquired immunodeficiency syndrome	0.000451	0.00716	CbGeAlD
Furosemide—CA4—digestive system—acquired immunodeficiency syndrome	0.00045	0.00714	CbGeAlD
Furosemide—CA1—nervous system—acquired immunodeficiency syndrome	0.000445	0.00706	CbGeAlD
Furosemide—SLCO2A1—lymph node—acquired immunodeficiency syndrome	0.000441	0.007	CbGeAlD
Furosemide—CA12—brain—acquired immunodeficiency syndrome	0.00043	0.00682	CbGeAlD
Furosemide—CA4—blood—acquired immunodeficiency syndrome	0.000429	0.0068	CbGeAlD
Furosemide—CA1—central nervous system—acquired immunodeficiency syndrome	0.000429	0.0068	CbGeAlD
Furosemide—CA4—bone marrow—acquired immunodeficiency syndrome	0.000415	0.00658	CbGeAlD
Furosemide—CA4—spinal cord—acquired immunodeficiency syndrome	0.000413	0.00655	CbGeAlD
Furosemide—PGD—brain—acquired immunodeficiency syndrome	0.000407	0.00645	CbGeAlD
Furosemide—PGD—lymph node—acquired immunodeficiency syndrome	0.000393	0.00624	CbGeAlD
Furosemide—CA5B—brain—acquired immunodeficiency syndrome	0.000385	0.00611	CbGeAlD
Furosemide—CA2—lymphoid tissue—acquired immunodeficiency syndrome	0.000378	0.00599	CbGeAlD
Furosemide—CA4—lung—acquired immunodeficiency syndrome	0.000376	0.00596	CbGeAlD
Furosemide—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.000376	0.00596	CbGeAlD
Furosemide—CA2—digestive system—acquired immunodeficiency syndrome	0.000373	0.00592	CbGeAlD
Furosemide—CA5B—lymph node—acquired immunodeficiency syndrome	0.000372	0.00591	CbGeAlD
Furosemide—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.000367	0.00582	CbGeAlD
Furosemide—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.000362	0.00574	CbGeAlD
Furosemide—CA2—blood—acquired immunodeficiency syndrome	0.000356	0.00564	CbGeAlD
Furosemide—SLC22A5—blood—acquired immunodeficiency syndrome	0.00035	0.00555	CbGeAlD
Furosemide—CA4—nervous system—acquired immunodeficiency syndrome	0.000348	0.00552	CbGeAlD
Furosemide—CA2—bone marrow—acquired immunodeficiency syndrome	0.000344	0.00546	CbGeAlD
Furosemide—CA2—spinal cord—acquired immunodeficiency syndrome	0.000343	0.00543	CbGeAlD
Furosemide—CA1—brain—acquired immunodeficiency syndrome	0.00034	0.0054	CbGeAlD
Furosemide—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000337	0.00535	CbGeAlD
Furosemide—CA4—central nervous system—acquired immunodeficiency syndrome	0.000335	0.00532	CbGeAlD
Furosemide—CA2—vagina—acquired immunodeficiency syndrome	0.00033	0.00523	CbGeAlD
Furosemide—CA1—lymph node—acquired immunodeficiency syndrome	0.000329	0.00522	CbGeAlD
Furosemide—SLC22A5—vagina—acquired immunodeficiency syndrome	0.000324	0.00514	CbGeAlD
Furosemide—CA2—lung—acquired immunodeficiency syndrome	0.000312	0.00494	CbGeAlD
Furosemide—SLC22A5—lung—acquired immunodeficiency syndrome	0.000307	0.00486	CbGeAlD
Furosemide—ALB—brain—acquired immunodeficiency syndrome	0.000299	0.00474	CbGeAlD
Furosemide—ALB—lymph node—acquired immunodeficiency syndrome	0.000289	0.00458	CbGeAlD
Furosemide—CA2—nervous system—acquired immunodeficiency syndrome	0.000289	0.00458	CbGeAlD
Furosemide—SLC22A8—brain—acquired immunodeficiency syndrome	0.000287	0.00455	CbGeAlD
Furosemide—CA2—central nervous system—acquired immunodeficiency syndrome	0.000278	0.00441	CbGeAlD
Furosemide—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000271	0.00429	CbGeAlD
Furosemide—CA4—brain—acquired immunodeficiency syndrome	0.000266	0.00422	CbGeAlD
Furosemide—CA4—lymph node—acquired immunodeficiency syndrome	0.000257	0.00408	CbGeAlD
Furosemide—CA2—brain—acquired immunodeficiency syndrome	0.000221	0.0035	CbGeAlD
Furosemide—SLC22A5—brain—acquired immunodeficiency syndrome	0.000217	0.00344	CbGeAlD
Furosemide—CA2—lymph node—acquired immunodeficiency syndrome	0.000213	0.00338	CbGeAlD
Furosemide—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.00021	0.00333	CbGeAlD
Furosemide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000161	0.000828	CcSEcCtD
Furosemide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000161	0.000828	CcSEcCtD
Furosemide—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00016	0.000826	CcSEcCtD
Furosemide—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000826	CcSEcCtD
Furosemide—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000826	CcSEcCtD
Furosemide—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000825	CcSEcCtD
Furosemide—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000822	CcSEcCtD
Furosemide—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000821	CcSEcCtD
Furosemide—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.00082	CcSEcCtD
Furosemide—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000159	0.00082	CcSEcCtD
Furosemide—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000159	0.00082	CcSEcCtD
Furosemide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000159	0.00082	CcSEcCtD
Furosemide—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.000818	CcSEcCtD
Furosemide—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000817	CcSEcCtD
Furosemide—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000158	0.000815	CcSEcCtD
Furosemide—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.000814	CcSEcCtD
Furosemide—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000813	CcSEcCtD
Furosemide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000158	0.000813	CcSEcCtD
Furosemide—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000812	CcSEcCtD
Furosemide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000157	0.000808	CcSEcCtD
Furosemide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000157	0.000808	CcSEcCtD
Furosemide—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000808	CcSEcCtD
Furosemide—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000806	CcSEcCtD
Furosemide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.000803	CcSEcCtD
Furosemide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000155	0.000801	CcSEcCtD
Furosemide—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000155	0.000801	CcSEcCtD
Furosemide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000155	0.0008	CcSEcCtD
Furosemide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000155	0.0008	CcSEcCtD
Furosemide—Headache—Didanosine—acquired immunodeficiency syndrome	0.000154	0.000796	CcSEcCtD
Furosemide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000154	0.000794	CcSEcCtD
Furosemide—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000793	CcSEcCtD
Furosemide—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000793	CcSEcCtD
Furosemide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000154	0.000791	CcSEcCtD
Furosemide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000153	0.00079	CcSEcCtD
Furosemide—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.00079	CcSEcCtD
Furosemide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000789	CcSEcCtD
Furosemide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000787	CcSEcCtD
Furosemide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000152	0.000784	CcSEcCtD
Furosemide—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000783	CcSEcCtD
Furosemide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000152	0.000783	CcSEcCtD
Furosemide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000152	0.000782	CcSEcCtD
Furosemide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000151	0.00078	CcSEcCtD
Furosemide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000151	0.00078	CcSEcCtD
Furosemide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000779	CcSEcCtD
Furosemide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000775	CcSEcCtD
Furosemide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000775	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000772	CcSEcCtD
Furosemide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000149	0.00077	CcSEcCtD
Furosemide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000149	0.000769	CcSEcCtD
Furosemide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000149	0.000769	CcSEcCtD
Furosemide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.000768	CcSEcCtD
Furosemide—Pain—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000762	CcSEcCtD
Furosemide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000762	CcSEcCtD
Furosemide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000148	0.000762	CcSEcCtD
Furosemide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.00076	CcSEcCtD
Furosemide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000147	0.000758	CcSEcCtD
Furosemide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000147	0.000758	CcSEcCtD
Furosemide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000147	0.000757	CcSEcCtD
Furosemide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.000756	CcSEcCtD
Furosemide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000146	0.000755	CcSEcCtD
Furosemide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000146	0.000755	CcSEcCtD
Furosemide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000753	CcSEcCtD
Furosemide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000753	CcSEcCtD
Furosemide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000751	CcSEcCtD
Furosemide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000751	CcSEcCtD
Furosemide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000749	CcSEcCtD
Furosemide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000144	0.000743	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000743	CcSEcCtD
Furosemide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000735	CcSEcCtD
Furosemide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000733	CcSEcCtD
Furosemide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000732	CcSEcCtD
Furosemide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000732	CcSEcCtD
Furosemide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000142	0.000732	CcSEcCtD
Furosemide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000731	CcSEcCtD
Furosemide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.00073	CcSEcCtD
Furosemide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000142	0.000729	CcSEcCtD
Furosemide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000141	0.000729	CcSEcCtD
Furosemide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.000727	CcSEcCtD
Furosemide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000141	0.000726	CcSEcCtD
Furosemide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.000726	CcSEcCtD
Furosemide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000724	CcSEcCtD
Furosemide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000724	CcSEcCtD
Furosemide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000723	CcSEcCtD
Furosemide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.00072	CcSEcCtD
Furosemide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.00072	CcSEcCtD
Furosemide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.00072	CcSEcCtD
Furosemide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00014	0.00072	CcSEcCtD
Furosemide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00014	0.00072	CcSEcCtD
Furosemide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000139	0.000718	CcSEcCtD
Furosemide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000716	CcSEcCtD
Furosemide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000139	0.000716	CcSEcCtD
Furosemide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.00071	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000709	CcSEcCtD
Furosemide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000137	0.000708	CcSEcCtD
Furosemide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000706	CcSEcCtD
Furosemide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000137	0.000705	CcSEcCtD
Furosemide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000137	0.000705	CcSEcCtD
Furosemide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000703	CcSEcCtD
Furosemide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.000703	CcSEcCtD
Furosemide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000702	CcSEcCtD
Furosemide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000136	0.000701	CcSEcCtD
Furosemide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000701	CcSEcCtD
Furosemide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000698	CcSEcCtD
Furosemide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000135	0.000698	CcSEcCtD
Furosemide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000135	0.000697	CcSEcCtD
Furosemide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000697	CcSEcCtD
Furosemide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000696	CcSEcCtD
Furosemide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000696	CcSEcCtD
Furosemide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000135	0.000695	CcSEcCtD
Furosemide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000695	CcSEcCtD
Furosemide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000135	0.000695	CcSEcCtD
Furosemide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000694	CcSEcCtD
Furosemide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000693	CcSEcCtD
Furosemide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000135	0.000693	CcSEcCtD
Furosemide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000134	0.000691	CcSEcCtD
Furosemide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000134	0.000691	CcSEcCtD
Furosemide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.00069	CcSEcCtD
Furosemide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000689	CcSEcCtD
Furosemide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000689	CcSEcCtD
Furosemide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000689	CcSEcCtD
Furosemide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.000688	CcSEcCtD
Furosemide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000133	0.000685	CcSEcCtD
Furosemide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000133	0.000684	CcSEcCtD
Furosemide—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000684	CcSEcCtD
Furosemide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000684	CcSEcCtD
Furosemide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000132	0.000681	CcSEcCtD
Furosemide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000132	0.000679	CcSEcCtD
Furosemide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000132	0.000678	CcSEcCtD
Furosemide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000673	CcSEcCtD
Furosemide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000671	CcSEcCtD
Furosemide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.00067	CcSEcCtD
Furosemide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.00067	CcSEcCtD
Furosemide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000669	CcSEcCtD
Furosemide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00013	0.000669	CcSEcCtD
Furosemide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.000666	CcSEcCtD
Furosemide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.000666	CcSEcCtD
Furosemide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000665	CcSEcCtD
Furosemide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000664	CcSEcCtD
Furosemide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000663	CcSEcCtD
Furosemide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000662	CcSEcCtD
Furosemide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000659	CcSEcCtD
Furosemide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000128	0.000657	CcSEcCtD
Furosemide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000127	0.000657	CcSEcCtD
Furosemide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.000656	CcSEcCtD
Furosemide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000127	0.000655	CcSEcCtD
Furosemide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000652	CcSEcCtD
Furosemide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000648	CcSEcCtD
Furosemide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000125	0.000645	CcSEcCtD
Furosemide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000644	CcSEcCtD
Furosemide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000643	CcSEcCtD
Furosemide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000643	CcSEcCtD
Furosemide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.00064	CcSEcCtD
Furosemide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000124	0.00064	CcSEcCtD
Furosemide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000639	CcSEcCtD
Furosemide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000638	CcSEcCtD
Furosemide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000637	CcSEcCtD
Furosemide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000637	CcSEcCtD
Furosemide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000637	CcSEcCtD
Furosemide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000637	CcSEcCtD
Furosemide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000123	0.000634	CcSEcCtD
Furosemide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000122	0.000631	CcSEcCtD
Furosemide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000624	CcSEcCtD
Furosemide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000621	CcSEcCtD
Furosemide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000619	CcSEcCtD
Furosemide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000618	CcSEcCtD
Furosemide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000614	CcSEcCtD
Furosemide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000614	CcSEcCtD
Furosemide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000613	CcSEcCtD
Furosemide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000613	CcSEcCtD
Furosemide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000118	0.00061	CcSEcCtD
Furosemide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000609	CcSEcCtD
Furosemide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000609	CcSEcCtD
Furosemide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000608	CcSEcCtD
Furosemide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000117	0.000604	CcSEcCtD
Furosemide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000604	CcSEcCtD
Furosemide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000117	0.000604	CcSEcCtD
Furosemide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000117	0.000601	CcSEcCtD
Furosemide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000596	CcSEcCtD
Furosemide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000595	CcSEcCtD
Furosemide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000594	CcSEcCtD
Furosemide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000592	CcSEcCtD
Furosemide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000591	CcSEcCtD
Furosemide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000591	CcSEcCtD
Furosemide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.00059	CcSEcCtD
Furosemide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000114	0.00059	CcSEcCtD
Furosemide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000589	CcSEcCtD
Furosemide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000589	CcSEcCtD
Furosemide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000587	CcSEcCtD
Furosemide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000585	CcSEcCtD
Furosemide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000585	CcSEcCtD
Furosemide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000578	CcSEcCtD
Furosemide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000576	CcSEcCtD
Furosemide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.00057	CcSEcCtD
Furosemide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.00057	CcSEcCtD
Furosemide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000111	0.000569	CcSEcCtD
Furosemide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000567	CcSEcCtD
Furosemide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000567	CcSEcCtD
Furosemide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000567	CcSEcCtD
Furosemide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000564	CcSEcCtD
Furosemide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000109	0.000562	CcSEcCtD
Furosemide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000109	0.000562	CcSEcCtD
Furosemide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.00056	CcSEcCtD
Furosemide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000558	CcSEcCtD
Furosemide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.000557	CcSEcCtD
Furosemide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000551	CcSEcCtD
Furosemide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000549	CcSEcCtD
Furosemide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000544	CcSEcCtD
Furosemide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000541	CcSEcCtD
Furosemide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000541	CcSEcCtD
Furosemide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000536	CcSEcCtD
Furosemide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000535	CcSEcCtD
Furosemide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000533	CcSEcCtD
Furosemide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000531	CcSEcCtD
Furosemide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000531	CcSEcCtD
Furosemide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000103	0.00053	CcSEcCtD
Furosemide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000528	CcSEcCtD
Furosemide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000528	CcSEcCtD
Furosemide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000527	CcSEcCtD
Furosemide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	9.99e-05	0.000515	CcSEcCtD
Furosemide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	9.94e-05	0.000512	CcSEcCtD
Furosemide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	9.9e-05	0.00051	CcSEcCtD
Furosemide—Rash—Delavirdine—acquired immunodeficiency syndrome	9.86e-05	0.000508	CcSEcCtD
Furosemide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	9.85e-05	0.000508	CcSEcCtD
Furosemide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	9.85e-05	0.000508	CcSEcCtD
Furosemide—Headache—Delavirdine—acquired immunodeficiency syndrome	9.8e-05	0.000505	CcSEcCtD
Furosemide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	9.78e-05	0.000504	CcSEcCtD
Furosemide—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.71e-05	0.0005	CcSEcCtD
Furosemide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.56e-05	0.000493	CcSEcCtD
Furosemide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.53e-05	0.000491	CcSEcCtD
Furosemide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.53e-05	0.000491	CcSEcCtD
Furosemide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	9.4e-05	0.000484	CcSEcCtD
Furosemide—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.29e-05	0.000479	CcSEcCtD
Furosemide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.21e-05	0.000474	CcSEcCtD
Furosemide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.2e-05	0.000474	CcSEcCtD
Furosemide—Rash—Ritonavir—acquired immunodeficiency syndrome	9.12e-05	0.00047	CcSEcCtD
Furosemide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.11e-05	0.000469	CcSEcCtD
Furosemide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.09e-05	0.000468	CcSEcCtD
Furosemide—Headache—Ritonavir—acquired immunodeficiency syndrome	9.06e-05	0.000467	CcSEcCtD
Furosemide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.85e-05	0.000456	CcSEcCtD
Furosemide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.78e-05	0.000453	CcSEcCtD
Furosemide—Rash—Saquinavir—acquired immunodeficiency syndrome	8.78e-05	0.000452	CcSEcCtD
Furosemide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.77e-05	0.000452	CcSEcCtD
Furosemide—Headache—Saquinavir—acquired immunodeficiency syndrome	8.72e-05	0.000449	CcSEcCtD
Furosemide—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.59e-05	0.000443	CcSEcCtD
Furosemide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.44e-05	0.000435	CcSEcCtD
Furosemide—Rash—Lamivudine—acquired immunodeficiency syndrome	8.37e-05	0.000431	CcSEcCtD
Furosemide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.37e-05	0.000431	CcSEcCtD
Furosemide—Headache—Lamivudine—acquired immunodeficiency syndrome	8.32e-05	0.000429	CcSEcCtD
Furosemide—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.27e-05	0.000426	CcSEcCtD
Furosemide—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.89e-05	0.000406	CcSEcCtD
